March 13, 2008 - - Echo Therapeutics (OTC Bulletin Board: ECTE) announced positive results from its clinical study of the Symphony(TM) tCGM System, a novel, non-invasive, transdermal continuous glucose monitoring (tCGM) system, conducted at the Tufts Medical Center in Boston, Massachusetts (Tufts). Echo is developing the Symphony tCGM System to provide patients with diabetes and healthcare professionals with a reliable, needle-free, wireless, continuous monitoring system to better manage diabetes and control blood glucose levels in the home use and hospital critical care settings. Data from the pilot study demonstrate that Symphony safely and reliably monitored blood glucose levels in the challenging operating room and surgical intensive care unit at Tufts. Echo is planning to present these data at a major medical conference later this year... [PDF] Echo Therapeutics' Press Release -
Thursday, March 27, 2008
Echo Therapeutics : Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
March 13, 2008 - - Echo Therapeutics (OTC Bulletin Board: ECTE) announced positive results from its clinical study of the Symphony(TM) tCGM System, a novel, non-invasive, transdermal continuous glucose monitoring (tCGM) system, conducted at the Tufts Medical Center in Boston, Massachusetts (Tufts). Echo is developing the Symphony tCGM System to provide patients with diabetes and healthcare professionals with a reliable, needle-free, wireless, continuous monitoring system to better manage diabetes and control blood glucose levels in the home use and hospital critical care settings. Data from the pilot study demonstrate that Symphony safely and reliably monitored blood glucose levels in the challenging operating room and surgical intensive care unit at Tufts. Echo is planning to present these data at a major medical conference later this year... [PDF] Echo Therapeutics' Press Release -
